Investors in Till Payments have won discovery for a possible suit over $43 million in alleged losses suffered after it was sold for just $47 million following a $200 million capital raise, with a judge rejecting arguments that the bid amounted to a royal commission.
An appeals court has tossed a challenge by construction firm Builtcom to an adjudication that slashed a $30 million payment claim against developer VSD Investments by $21 million, saying mere legal error was not enough.
Owners of apartments at Meriton’s Alcove St Ives will fight a defence by the developer’s building unit they say goes against court orders made allowing them to greatly expand their case.
Although Meriton’s contractor prevailed in a cladding spat over Brisbane’s Infinity Tower, the owners corporation’s arguments were not at all stages “without merit”, a QCAT member has said in declining to award the builder its costs.
Challenging an $8.5 million adjudication on a payment claim that sought over $30 million from developer VSD Investments, construction company Builtcom says it is effectively “disabled” from recovery of progress payments.
An appeals court has rejected Keybridge CEO Nick Bolton’s challenge to a ruling that found that he and two other directors were validly removed at a board meeting, finding in favour of shareholder WAM Active.
It lost its bid in the NSW Supreme Court to withhold a payment claim from the builder of a 30-storey project in Sydney pending an appeal, now developer VSD Investments has asked an appeals court to halt payment.
Developer VSD Investments has lost an argument for withholding an $8.5 million payment claim from the builder of a 30-storey project in Sydney’s inner west pending the construction company’s appeal.
Builtcom has lost a challenge to an adjudicator’s $8.5 million determination of a final payment claim under a contract with VSD Investments for construction of a 30-storey development in Sydney’s inner west.
A judge has declined Meriton’s bid for $2.4 million in security in a lawsuit over alleged systemic defects at the Alcove apartment development in Sydney’s North Shore.